WHO Director-General — Anti-viral Drug Remdesivir Is Not The Real McCoy

Dr. Tedros Adhanom Ghebreyesus, in a recent press briefing, said that in the World Health Organization’s Solidarity Trial to test the effectiveness of four drugs, it found that Remdesivir and interferon have little or no effect in preventing death from COVID-19 or reducing time in hospital.

He noted that the Solidarity Trial is the world’s largest randomized controlled trial of COVID-19 therapeutics, involving almost 13,000 patients in 500 hospitals in 30 countries.

He further said that in June, WHO announced the discontinuation hydroxychloroquine arm of its study.

He also said that the organization announced in July that it would no longer enroll patients to receive the combination of lopinavir and ritonavir.

The Director-General stated that only the corticosteroid dexamethasone therapeutic has proved effective against COVID-19 for patients with severe disease.

He also posited that many other ongoing therapeutics trials had been identified through the Research and Development Roadmap for COVID-19.

He said that through the ACT Accelerator, WHO remains committed to speeding up vaccines, diagnostics, and therapeutics for COVID-19 and ensuring equitable distribution.

Nigel Bell Readers Bureau, Contributor

Edited by Jesus Chan

Do you want to add feedback to this story? Please add a comment in the e-mail box below, send an email to info@thereadersbureau.comsend us a message on WhatsApp at 646-874-7976 or Call us at 201-500-7715